Detalhe da pesquisa
1.
Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Major Depressive Disorder (MDD): A Systematic Review.
Int J Mol Sci
; 24(19)2023 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37834258
2.
BDNF and Cognitive Function in Chilean Schizophrenic Patients.
Int J Mol Sci
; 24(13)2023 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37445746
3.
Polymorphisms in Schizophrenia-Related Genes Are Potential Predictors of Antipsychotic Treatment Resistance and Refractoriness.
Int J Neuropsychopharmacol
; 25(9): 701-708, 2022 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35416253
4.
Effects of socioeconomic status in cognition of people with schizophrenia: results from a Latin American collaboration network with 1175 subjects.
Psychol Med
; 52(11): 2177-2188, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34158132
5.
Effects of Socioeconomic Status in Cognition of People with Schizophrenia: Results From a Latin American Collaboration Network with 1175 Subjects - CORRIGENDUM.
Psychol Med
; 52(11): 2198, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35527709
6.
Montreal Cognitive Assessment (MoCA) as a screening tool for cognitive impairment in early stages of psychosis.
Schizophr Res Cogn
; 36: 100302, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38323136
7.
BDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review.
Front Psychiatry
; 12: 662407, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34220575